Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs

The shear-responsive transcription factor Krüppel-like factor 2 (KLF2) is a critical regulator of endothelial gene expression patterns induced by atheroprotective flow. As microRNAs (miRNAs) post-transcriptionally control gene expression in many pathogenic and physiological processes, we investigate...

Full description

Saved in:
Bibliographic Details
Published inNature cell biology Vol. 14; no. 3; pp. 249 - 256
Main Authors Hergenreider, Eduard, Heydt, Susanne, Tréguer, Karine, Boettger, Thomas, Horrevoets, Anton J. G., Zeiher, Andreas M., Scheffer, Margot P., Frangakis, Achilleas S., Yin, Xiaoke, Mayr, Manuel, Braun, Thomas, Urbich, Carmen, Boon, Reinier A., Dimmeler, Stefanie
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2012
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The shear-responsive transcription factor Krüppel-like factor 2 (KLF2) is a critical regulator of endothelial gene expression patterns induced by atheroprotective flow. As microRNAs (miRNAs) post-transcriptionally control gene expression in many pathogenic and physiological processes, we investigated the regulation of miRNAs by KLF2 in endothelial cells. KLF2 binds to the promoter and induces a significant upregulation of the miR-143/145 cluster. Interestingly, miR-143/145 has been shown to control smooth muscle cell (SMC) phenotypes; therefore, we investigated the possibility of transport of these miRNAs between endothelial cells and SMCs. Indeed, extracellular vesicles secreted by KLF2-transduced or shear-stress-stimulated HUVECs are enriched in miR-143/145 and control target gene expression in co-cultured SMCs. Extracellular vesicles derived from KLF2-expressing endothelial cells also reduced atherosclerotic lesion formation in the aorta of ApoE −/−  mice. Combined, our results show that atheroprotective stimuli induce communication between endothelial cells and SMCs through an miRNA- and extracellular-vesicle-mediated mechanism and that this may comprise a promising strategy to combat atherosclerosis. Dimmeler and colleagues show that the atheroprotective transcription factor KLF2 activates expression of the microRNAs miR-143/145 in endothelial cells. miR-143/145 are subsequently enriched in secreted microvesicles and taken up by smooth muscle cells to elicit anti-atherogenic responses.
ISSN:1465-7392
1476-4679
DOI:10.1038/ncb2441